Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Hemlibra
Hemlibra
Novo Nordisk unwraps phase 3 hemophilia A data, revealing how Roche rivalry may shake out
Fierce Biotech
Mon, 06/24/24 - 10:54 am
Novo Nordisk
Mim8
hemophilia A
clinical trials
Roche
Hemlibra
Roche’s Hemlibra shows benefit in Phase III hemophilia A trial
Clinical Trials Arena
Mon, 12/11/23 - 09:57 am
Roche
Hemlibra
hemophilia A
clinical trials
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
Fierce Biotech
Tue, 06/27/23 - 10:36 pm
Novo Nordisk
hemophilia
clinical trials
Pfizer
Roche
Hemlibra
Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Sanofi
FDA
clinical trials
hemophilia A
efanesoctocog alfa
Roche
Hemlibra
Genentech Hemophilia A Drug Displays Long-term Safety, Efficacy
BioSpace
Mon, 07/19/21 - 11:09 pm
Genentech
Hemlibra
hemophilia A
clinical trials
Novimmune unit nabs Takeda milestone payment for hemophilia work
Fierce Biotech
Fri, 02/14/20 - 10:40 am
Takeda
Light Chain Bioscience
Novimmune
R&D
Hemlibra
hemophilia A
Thrashed by a 'surprise' rival, Sanofi writes off $2B on soured hemophilia deal
Endpoints
Mon, 07/29/19 - 09:39 am
Sanofi
earnings
Roche
Hemlibra
hemophilia
Eloctate
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Fierce Pharma
Fri, 04/26/19 - 07:39 pm
Sanofi
Bioverativ
M&A
diabetes
Eloctate
Roche
Hemlibra
Roche's pharma business is booming, for now
BioPharma Dive
Wed, 04/17/19 - 12:27 pm
Roche
earnings
Hemlibra
IP trouble defers launch of Novo's long-acting hemophilia therapy
Endpoints
Wed, 02/20/19 - 10:03 am
Novo Nordisk
Eseproct
hemophilia
Roche
Hemlibra
China approves Descovy, Harvoni, Hemlibra
BioCentury
Tue, 12/4/18 - 11:51 pm
China
Harvoni
Descovy
Hemlibra
Roche
Gilead Sciences
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom
Xconomy
Thu, 10/4/18 - 06:52 pm
hemophilia A
FDA
Roche
Hemlibra
Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling
BioSpace
Tue, 09/18/18 - 10:14 pm
FDA
Genentech
Hemlibra
hemophilia
Roche reveals haemophilia drug data ahead of label expansion decision
Pharmaforum
Fri, 08/31/18 - 11:51 am
Roche
hemophilia A
FDA
Hemlibra
Roche drug dramatically reduces bleeds in key hemophilia tests
Reuters
Mon, 05/21/18 - 10:13 am
Roche
Hemlibra
clinical trials
hemophilia A
Roche flags first case of anti-drug antibodies that forced a patient to drop would-be blockbuster Hemlibra
Endpoints
Thu, 04/26/18 - 11:11 am
Roche
hemophilia
Hemlibra
anti-drug antibodies
Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing
Fierce Pharma
Tue, 04/17/18 - 11:33 am
Roche
Hemlibra
hemophilia
FDA
breakthrough status
ICER
Under fire for 5 deaths of patients taking Hemlibra, Roche spills details
Fierce Pharma
Fri, 03/30/18 - 05:56 pm
Hemlibra
Roche
hemophilia
Hemophilia groups warned of 5 deaths among patients taking Roche’s big new blockbuster Hemlibra
Endpoints
Tue, 03/27/18 - 10:13 pm
hemophilia
Roche
Hemlibra
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Pages
1
2
next ›
last »